Immune Response after Vaccination with Recombinant Hepatitis Surface Antigen in Maintenance Hemodialysis Patients and Healthy Controls
- 1 January 1992
- journal article
- clinical trial
- Published by S. Karger AG in Nephron
- Vol. 61 (3) , 339-340
- https://doi.org/10.1159/000186932
Abstract
We evaluated anti-HBs titers 2 months after vaccination with recombinant hepatitis surface antigen (rDNA-HBsAg) in 43 maintenance hemodialysis patients (MHP). Of these, 34 had not undergone hepatitis B virus vaccination previously (NV-MHP) and 9 had shown negative response to vaccination with plasma-derived HBsAg (HEVAC Pasteur; V-MHP). 120 healthy workers from the same hospital undergoing rDNA-HBsAg immunization were used as controls. All low responders (LR) (anti-HBsKeywords
This publication has 0 references indexed in Scilit: